Sciety

We couldn't get details of this article at this time:
10.1101/2021.09.30.462488
SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies

This article has 34 authors:
1. S. Momsen Reincke
2. Meng Yuan
3. Hans-Christian Kornau
4. Victor M. Corman
5. Scott van Hoof
6. Elisa Sánchez-Sendin
7. Melanie Ramberger
8. Wenli Yu
9. Yuanzi Hua
10. Henry Tien
11. Marie Luisa Schmidt
12. Tatjana Schwarz
13. Lara Maria Jeworowski
14. Sarah E. Brandl
15. Helle Foverskov Rasmussen
16. Marie A. Homeyer
17. Laura Stöffler
18. Martin Barner
19. Désirée Kunkel
20. Shufan Huo
21. Johannes Horler
22. Niels von Wardenburg
23. Inge Kroidl
24. Tabea M. Eser
25. Andreas Wieser
26. Christof Geldmacher
27. Michael Hoelscher
28. Hannes Gänzer
29. Günter Weiss
30. Dietmar Schmitz
31. Christian Drosten
32. Harald Prüss
33. Ian A. Wilson
34. Jakob Kreye
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Feb 18, 2022Latest activity Oct 4, 2021
Use of eVLP-based vaccine candidates to broaden immunity against SARS-CoV-2 variants

This article has 11 authors:
1. Jasminka Bozic
2. Tanvir Ahmed
3. Barthelemy Ontsouka
4. Anne-Catherine Fluckiger
5. Abebaw Diress
6. Tamara Berthoud
7. Xiaoyang Yuan
8. Lanjian Yang
9. Francisco Diaz-Mitoma
10. David E. Anderson
11. Catalina Soare
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Sep 29, 2021Latest activity Oct 2, 2021
A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in rhesus macaques

This article has 22 authors:
1. Ronald R. Cobb
2. Joseph Nkolola
3. Pavlo Gilchuk
4. Abishek Chandrashekar
5. Robert V. House
6. Christopher G. Earnhart
7. Nicole M. Dorsey
8. Svetlana A. Hopkins
9. Doris M. Snow
10. Rita E. Chen
11. Laura A. VanBlargan
12. Manuel Hechenblaikner
13. Brian Hoppe
14. Laura Collins
15. Milan T. Tomic
16. Genevieve H. Nonet
17. Kyal Hackett
18. James C. Slaughter
19. Michael S. Diamond
20. Robert H. Carnahan
21. Dan H. Barouch
22. James E. Crowe
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Sep 29, 2021Latest activity Oct 1, 2021
We couldn't get details of this article at this time:
10.1101/2021.09.27.462006
We couldn't get details of this article at this time:
10.1101/2021.09.27.461862
We couldn't get details of this article at this time:
10.1101/2021.09.27.461948
SARS-CoV-2 spike-specific memory B cells express higher levels of T-bet and FcRL5 after non-severe COVID-19 as compared to severe disease

This article has 10 authors:
1. Raphael A. Reyes
2. Kathleen Clarke
3. S. Jake Gonzales
4. Angelene M. Cantwell
5. Rolando Garza
6. Gabriel Catano
7. Robin E. Tragus
8. Thomas F. Patterson
9. Sebastiaan Bol
10. Evelien M. Bunnik
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Dec 22, 2021Latest activity Sep 30, 2021
We couldn't get details of this article at this time:
10.1101/2021.07.15.452458
A Recombinant Subunit Vaccine Induces a Potent, Broadly Neutralizing, and Durable Antibody Response in Macaques against the SARS-CoV-2 P.1 (Gamma) Variant

This article has 17 authors:
1. Albert To
2. Teri Ann S. Wong
3. Michael M. Lieberman
4. Karen Thompson
5. Aquena H. Ball
6. Laurent Pessaint
7. Jack Greenhouse
8. Nisrine Daham
9. Anthony Cook
10. Brandon Narvaez
11. Zack Flinchbaugh
12. Alex Van Ry
13. Jake Yalley-Ogunro
14. Hanne Andersen Elyard
15. Chih-Yun Lai
16. Oreola Donini
17. Axel T. Lehrer
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 9, 2022Latest activity Sep 28, 2021

Previous Page 96 of 175 Next

SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies

Use of eVLP-based vaccine candidates to broaden immunity against SARS-CoV-2 variants

A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in rhesus macaques

SARS-CoV-2 spike-specific memory B cells express higher levels of T-bet and FcRL5 after non-severe COVID-19 as compared to severe disease

A Recombinant Subunit Vaccine Induces a Potent, Broadly Neutralizing, and Durable Antibody Response in Macaques against the SARS-CoV-2 P.1 (Gamma) Variant